Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Wirth Peter, Director. Director active across 3 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 13 filings have been recorded. Split: 2 buys · 1 sell. Total volume traded: €636k. Activity tracked since 17 June 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wirth Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Peter Wirth is Administrateur at Zai Lab Ltd, Syros Pharmaceuticals, Inc. and Forma Therapeutics Holdings, Inc. He has 13 filings, and across the 13 sampled filings the buy and sell volumes are EUR 506256 and EUR 129594, with filings dated from 2021-06-21 to 2025-06-23; the most common transaction nature is Attribution.